Displaying items by tag: oneal comprehensive cancer center

Growing a garden helps cancer survivors eat better, but the benefits extend beyond the harvest, UAB study reveals.
UAB epidemiologist Christine Skibola used genomics to identify a DNA variant that makes some susceptible to leukemia.
Researchers identify the strategy that highly aggressive brain tumor cells use to fuel their relentless expansion and reveal a fresh target for cancer therapy.
With pilot finds from young professionals, Division of Preventive Medicine Assistant Professor Tiffany Carson, Ph.D., will build the foundation of her research program studying factors that influence cancer disparities of black and white women in the South.
The UAB Comprehensive Cancer Center has been selected as a  lead academic site and received a prestigious NCI grant that will open up clinical trials across a nationwide network and expand treatment options for patients.
The UAB Comprehensive Cancer Center’s May 1 Fiesta Ball will support the work of UAB’s young cancer research scientists.
Leonard Sender, M.D., chairman of Stupid Cancer, the largest adolescent and young adult cancer survivor’s advocacy group in the United States, will be the featured keynote speaker.
A UAB study will pair master gardeners with breast cancer survivors in an effort to promote a healthy diet and physical exercise.

PNP Therapeutics, UAB and Southern Research Institute work abolishes otherwise unmanageable human cancers in preclinical rodent studies.

The Bartow Classic recognizes the late UAB Men’s Basketball Coach and Athletics Director Gene Bartow for his decades of commitment to UAB and intercollegiate sports.
Ballroom-dance intervention seeks to improve health, relationships for women with reproductive cancers and their partners – participants receive free dance lessons.

A fungal toxin may suppress immune system and drive HIV infection in developing countries.

The fund will benefit cancer patients who are facing demonstrable financial hardship to help offset the cost of their treatment.

Biomarkers could tailor preventative or therapeutic aspirin regimens by predicting colorectal cancer patients’ response.

A Department of Neurosurgery, effective Oct. 1, 2013, will increase the profile of an internationally renowned program.

Page 26 of 33